IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9693997 B1

PDFFull Text
Date of Patent:
Jul. 04, 2017

Filed:

Mar. 03, 2014

Antiviral compounds

Applicant:

Hoffmann-la Roche Inc., Nutley, NJ (US);

Inventors:

Joseph Anthony Bilotta, Nutley, NJ (US);

Zhi Chen, Livingston, NJ (US);

Feng Chi, Basking Ridge, NJ (US);

Elbert Chin, San Mateo, CA (US);

Qingjie Ding, Bridgewater, NJ (US);

Shawn David Erickson, Leonia, NJ (US);

Stephen Deems Gabriel, Morristown, NJ (US);

Nan Jiang, Pine Brook, NJ (US);

Buelent Kocer, Maulburg, DE;

Eric Mertz, Fair lawn, NJ (US);

Jean-Marc Plancher, Hagenthal-le-Bas, FR;

Robert J. Weikert, Basel, CH;

Jing Zhang, Parsippany, NJ (US);

Qiang Zhang, East Brunswick, NJ (US);

Assignee:

HOFFMANN-LA ROCHE INC., Nutley, NJ (US);

Attorney:
Primary Examiner:

Alicia L Otton

Int. Cl.
CPC ...
C07D 249/14 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/12 (2006.01); C07D 417/12 (2006.01); C07D 491/107 (2006.01); C07D 495/04 (2006.01); A61K 31/4196 (2006.01); A61K 31/454 (2006.01); A61K 31/428 (2006.01); A61K 31/496 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/541 (2006.01); A61K 31/5415 (2006.01); A61K 45/06 (2006.01); C07D 411/12 (2006.01); C07D 413/12 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4196 (2013.01); A61K 31/428 (2013.01); A61K 31/454 (2013.01); A61K 31/496 (2013.01); A61K 31/538 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 31/5415 (2013.01); A61K 45/06 (2013.01); C07D 249/14 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 411/12 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 491/107 (2013.01); C07D 495/04 (2013.01);
Abstract

The present invention discloses compounds of Formula I: wherein the variables in Formula I are defined as described herein. Also disclosed are pharmaceutical compositions containing such compounds and methods for using the compounds of Formula I in the prevention or treatment of HCV infection.

Find Patent Forward Citations

Loading…